CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Planned sale President sold 2,000 shares at $79.65 ($159,300)
- 4 Planned sale Director sold 11,487 shares at an average $87.16 ($1,001,218)
- 4 Grant or award Director acquired 1,345 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CFO and Treasurer gave up 786 shares (to pay taxes)
- 4 Planned sale Director sold 1,000 shares at $98.52 ($98,520)
- 4 Grant or award Chief Accounting Officer acquired 4,731 shares (grant or award)
- 4 Planned sale See Remarks sold 2,500 shares at $97.54 ($243,850)
- 4 Planned sale Director sold 15,500 shares at an average $96.48 ($1,495,396)
- 4 Planned sale President sold 2,000 shares at $96.39 ($192,780)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 10,481 shares at an average $95.50 ($1,000,900)
- 4 Shares withheld for taxes President gave up 518 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 2,137 shares at an average $124.67 ($266,417)
- 4 Planned sale Director sold 12,530 shares at $95.04 ($1,190,851)
- 4 Grant or award Chief Medical Officer acquired 9,076 shares (grant or award)
- 4 Planned sale Chief Accounting Officer sold 341 shares at $79.77 ($27,202)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President sold 1,179 shares at $80.82 ($95,287)
- 4 Planned sale See Remarks sold 12,873 shares at $79.86 ($1,028,038)
Page 5 of 30 · 598 filings